|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3475303 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17735440.4 |
| Date of filing the European patent application | 2017-06-27 | |
| (97) | Date of publication of the European application | 2019-05-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation | 2021-06-25 |
| (86) | Number | PCT/EP2017/065819 |
| Date | 2017-06-27 |
| (87) | Number | WO 2018/002031 |
| Date | 2018-01-04 |
| (30) | Number | Date | Country code |
| 16176322 | 2016-06-27 | EP |
| (72) |
GARIDEL, Patrick, DE
LANGER, Andreas, DE
HESSLING, Martin, DE
WEINFURTNER, Daniel, DE
BROCKS, Bodo, DE
|
| (73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, Delaware 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-CD19 antikūno kompozicijos |
| ANTI-CD19 ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-06-26 | 9 | 208.00 EUR |
| 2026-06-27 |